一本性道在线视频无码看|97人妻人人做人碰人人爽|熟女俱乐部五十路六十路av|国产亚洲精品日韩香蕉网

Essex-Bio Group

簡繁 EN

COMPANY NEWS

Essex Bio-Technology (1061.HK) 2023 Annual Results at a glance

2024.03.19

Essex Bio-Technology Posts Sound 2023 Annual Financial Results: Revenue Up 29.5%, Profit Up 22.1%

2024.03.18

Change of Address of Head Office and Principal Place of Business in Hong Kong

2024.01.03

Date

Title

2024-03-19

Essex Bio-Technology (1061.HK) 2023 Annual Results at a glance

2024-03-18

Essex Bio-Technology Posts Sound 2023 Annual Financial Results: Revenue Up 29.5%, Profit Up 22.1%

2024-01-03

Change of Address of Head Office and Principal Place of Business in Hong Kong

2023-08-16

Essex Bio-Technology (1061.HK) 2023 Interim Results at a glance

2023-08-16

Essex Bio-Technology Posts Sound 2023 Interim Financial Results Revenue Up 37.1%, Profit Up 22%

2023-07-26

The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed

2023-06-30

EssexBio awarded “2022 China Pharmaceutical Industry Top 100 Series List” and “2023 China Pharmaceutical Brands List”

2023-04-14

Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore

Essex-Bio Group

BIOTECH

HEALTHTECH

Links

Copyright ? 2020 Essex Bio-Technology Limited All Rights Reserved.
Disclaimer | Privacy Policy

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT

<form id='fgwhV'></form>

<bdo id='kmK3C'><sup id='qDsff'><div id='iCWVu'><bdo id='gIR0M'></bdo></div></sup></bdo>